跳至主要内容
临床试验/NCT02093858
NCT02093858Unknown不适用

The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic Syndrome

Central South University1 个研究点 分布在 1 个国家目标入组 212 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
212
试验地点
1
主要终点
Change in weight and blood glucose

研究概览

简要总结

Almost all of antipsychotics can induce metabolic syndrome,Genetic factors play a key role in the development of metabolic syndrome,TCF7L2 and SLC30A8 are strongestly correlated with metabolic syndrome.Moreover,Antipsychotics have an effect on the expression of TCF7L2 and SLC30A8 genes.It indicates the variations of TCF7L2 and SLC30A8 play an important part in the development of antipsychotics-induced metabolic syndrome.

详细描述

  • In this study, we will determine the effect of olanzapine on the expression of TCF7L2 and SLC30A8.
  • The relationship of the polymorphism of TCF7L2 and SLC30A8 with antipsychotic-induced metabolic syndrome in schizophrenia patients.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of first episode schizophrenia
  • Must be able to swallow tablets
  • Take only one antipsychotics

排除标准

  • liver or renal or cardiovascular diseases
  • pregnant or lactating women
  • drug and alcohol dependence

结局指标

主要结局

Change in weight and blood glucose

时间窗: 24 weeks

次要结局

  • Change of the blood pressure and blood lipid(24 weeks)

研究者

发起方
Central South University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Renrong Wu

PhD

Central South University

研究点 (1)

Loading locations...

相似试验